Since 2000, LRAAC has conducted research for new treatments for allergies and asthma. In our 17 years we have completed over 150 clinical trials. If you would like to contact us regarding information about current clinical trials at LRAAC, call Mindy DeMarco RN,BSN,CCRP at 501-224-1156 Option 7.

Biocryst HAE: Oral treament for prevention of HAE attacks. Compensation up to $2800

Updated 2-5-18

GSK 107116: Children 4-17 with Uncontrolled Asthma. Compensation up to $630

Updated 2-5-18

EVA 21287: Patient perception of biologics in severe asthma. Compensation up to $100

Phone interview

Novartis CQGE031C2201E1: Adults with Chronic Urticaria

In follow up- completed enrollment 4/2017

Stallergenes : House Dust Mite Allergy Oral Immunotherapy

In follow up- completed enrollment 5/2017

CAPSTONE 2: Influenza Treatment in High Risk Flu Patients

Updated 2-5-18

GSK 205715: Adults 18+ with Inadequately Controlled Asthma, 9 Visits over 13 Months, Compensation up to $1235

Updated 6-20-17

GSK 114971: Males 5-8 and Females 5-7 with Asthma, 20 Visits over 16 months, Compensation up to $1100

Updated 6-20-17

TEVA FSS-AS-30003: Patients 4-11 with Persistent Asthma, 9 Visits over 12 Weeks, Compensation up to $450

Updated 6-20-17

Little Rock Allergy & Asthma CRC

18 Corporate HIll, Suite 110
Little Rock, AR 72205
Phone: +1 (501) 224-1156
Fax: +1 (501) 537-2090